On 18 May 2012, a heart revive centre was inaugurated at a cost of ₹300 million, with a full-fledged cathlab and an electro-physiology laboratory for the treatment of arrhythmia, or irregular heartbeat.

Globally, a kidney transplant has never been reported in a recipient with the Bombay O blood group due to the rarity and higher complications involved.

Additionally, the lack of precedents or guidelines for monitoring anti-H antibody levels, which are significant in preventing organ rejection, made the transplantation highly challenging.

[5][6][7][8] The MIOT Institute of Haematology, Haemato-Oncology & BMT performed the first T-replete haplo identical bone marrow transplant in India in 2013.

[10][11][12] For the first time in India, MIOT Hospitals brings a Biplane CathLab with Cone Beam CT, 3D Echo and software intelligence – all on a single platform.